肝配蛋白B2(EFNB2)真核蛋白
Eukaryotic Ephrin B2 (EFNB2)
EPLG5; HTKL; Htk-L; LERK5; HTK Ligand; Ligand Of Eph-Related Kinase 5; Eph-Related Receptor Tyrosine Kinase Ligand 5
- 編號(hào)EPE112Mu61
- 物種Mus musculus (Mouse,小鼠) 相同的名稱,不同的物種。
- 來(lái)源真核表達(dá)
- 宿主293F cell
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量48.8kDa
- 實(shí)際分子量60kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
- 片段與標(biāo)簽Arg29~Glu227 with N-terminal His Tag and C-terminal Fc Region of Human IgG1
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)7.9
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1104 ¥ 2760 ¥ 5520 ¥ 16560 ¥ 41400
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APE112Mu61 | 肝配蛋白B2(EFNB2)活性蛋白 | Cell?culture;?Activity?Assays. |
EPE112Mu61 | 肝配蛋白B2(EFNB2)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPE112Mu02 | 肝配蛋白B2(EFNB2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPE112Mu01 | 肝配蛋白B2(EFNB2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAE112Mu01 | 肝配蛋白B2(EFNB2)多克隆抗體 | WB; IHC; ICC; IP. |
PAE112Mu02 | 肝配蛋白B2(EFNB2)多克隆抗體 | WB; IHC; ICC; IP. |
SEE112Mu | 肝配蛋白B2(EFNB2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LME112Mu | 肝配蛋白B2(EFNB2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
ATS Journals | Soluble Ephrin-B2 is a Novel Biomarker for Idiopathic Pulmonary Fibrosis [Doi: Pdf] |
D50. PEDIATRIC RARE LUNG DISEASES | Soluble Ephrin-B2 Is A Novel Biomarker Of Pulmonary Fibrosis [doi:A7217] |
An International Journal of Medicine? | P055 Over-expression of IL-6 and OSM impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis [content:109] |
An International Journal of Medicine | P057 Soluble Ephrin-B2 is a Prognostic Biomarker of Pulmonary Fibrosis [S40.2.extract] |
4 | ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis [pubmed:29058717] |
留言咨詢